Journal Article

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)

Moliere, F., Dorey, J.-M., Bougerol, T., Camus, V., Yrondi, A., Haesebaert, F., Doumy, O., Leboyer, M., Courtet, P., Vaiva, G., Charpeaud, T., Richieri, R., Holtzmann, J., Lançon, C., Stephan, F., Allaili, N., Destouches, S., Lefebvre, M., Bennabi, D., Nieto, I., Llorca, P.-M., Lancrenon, S., Bellivier, F., El-Hage, W., Genty, J.-B., Aouizerate, B., Haffen, E., Schmitt, L., Rabu, C., Walter, M.

2019

Overview

Background Recommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking. Method The French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments. Results The expert guidelines combine scientific evidence and expert clinician’s opinion to produce recommendations for major depression with comorbid anxiety disorders, personality disorders or substance use disorders and in geriatric depression. Conclusion These guidelines provide direction addressing common clinical dilemmas that arise in the pharmacologic treatment of major depression with comorbid psychiatric conditions.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Aged / Alcohol / Analysis / Antidepressants / Anxiety / Anxiety disorders / Anxiety Disorders - epidemiology / Anxiety Disorders - psychology / Anxiety Disorders - therapy / Associations / Biological Psychiatry - methods / Biological Psychiatry - standards / Care and treatment / Clinical practice guidelines / Comorbidity / Data processing / Depressive Disorder, Major - epidemiology / Depressive Disorder, Major - psychology / Depressive Disorder, Major - therapy / Drug therapy / Drug use / Elderly / Expert evidence / Expert Testimony - methods / Expert Testimony - standards / Female / Foundations - standards / France - epidemiology / Geriatric depression / Geriatrics / Human health and pathology / Humans / Information management / Life Sciences / Major depressive disorder / Male / Medicine / Medicine & Public Health / Mental depression / Meta-analysis / Mood disorders / Neuropsychology / Neuropsychopharmacology / Neuroses / Obsessive compulsive disorder / Oxazepam / Personality disorders / Personality Disorders - epidemiology / Personality Disorders - psychology / Personality Disorders - therapy / Pharmacotherapy / Practice guidelines (Medicine) / Practice Guidelines as Topic - standards / Psychiatrics and mental health / Psychiatrists / Psychiatry / Psychiatry - standards / Psychopharmacology - methods / Psychopharmacology - standards / Psychotherapy / Public health / Research Article / Serotonin / Substance abuse / Substance abuse treatment / Substance use disorder / Substance use disorders / Substance-Related Disorders - epidemiology / Substance-Related Disorders - psychology / Substance-Related Disorders - therapy / Systematic review